Sp1285
EOSINOPHILIC ESOPHAGITIS: DISCOVER A TREATMENT OPTION FOR YOUR PATIENTS
Date
May 8, 2023
Society: DDW
Take an afternoon break with us to learn about a treatment option for your appropriate patient with eosinophilic esophagitis. An expert will walk us through long-term clinical data, an example of an appropriate patient, and answer your questions! Sponsored by Sanofi and Regeneron
Take an afternoon break with us to learn about a treatment option for your appropriate patient with eosinophilic esophagitis. An expert will walk us through long-term clinical data, an example of an appropriate patient, and answer your questions! Sponsored by Sanofi and Regeneron
Presenter
Tracks
Related Products
DUPILUMAB IS EFFICACIOUS IN EOSINOPHILIC ESOPHAGITIS REGARDLESS OF PRIOR USE OR PRIOR INADEQUATE RESPONSE, INTOLERANCE, OR CONTRAINDICATION TO SWALLOWED TOPICAL CORTICOSTEROIDS: RESULTS FROM PART C OF THE LIBERTY-EOE-TREET STUDY
BACKGROUND: Gut dysbiosis is associated with persistent multi-system symptoms following SARS-CoV-2 infection, or post-acute COVID-19 syndrome (PACS). We performed a randomised controlled trial to assess the effects of gut microbiome modulation on alleviation of PACS symptoms…
FLUTICASONE PROPRIONATE ORAL DISINTEGRATING TABLET, APT-1011, IMPROVES FIBROSTENOTIC FEATURES OF STRICTURES AND GRADE 2/3 RINGS IN SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS (EOE)
Esophageal eosinophilic inflammation and remodeling lead to fibrostenosis in many patients with eosinophilic esophagitis (EoE)…
